Ultrasound contrast agents can transform the role of ultrasound, allowing clinicians to study the enhancement patterns of liver lesions in real time, providing faster and more definitive diagnoses.
With Philips ultrasound, contrast enhanced ultrasound is seamlessly integrated into the standard workflow, providing exceptional detail throughout arterial, portal, and late phase scanning. Additionally, with advanced technologies such as MaxVue, PureWave C9-2 transducer, fusion Imaging and integrated quantification via Philips Q-Apps, maximum confidence and the ultimate liver solution becomes a reality even in the most challenging exams.
Landing
